The non-hormonal therapies market is projected to be worth USD 10.9 billion in 2030

Roots Analysis is pleased to announce the publication of its recent study, titled, “Non-hormonal Therapies for Women’s Health Market .

Advertisements

 

The report features an extensive study of the current market landscape of non-hormonal therapies, primarily focusing on prescription drugs. The study also includes an elaborate discussion on the future potential of this evolving market. Amongst other elements, the report features:

  • A detailed assessment of the overall market landscape of non-hormonal therapies based on various relevant parameters such as phase of development and type of molecule.
  • A detailed review of the players engaged in the development of non-hormonal therapies based on their year of establishment, company size, location of headquarters and regional landscape.
  • An elaborate discussion on the various commercialization strategies that can be adopted by the drug developers engaged in this domain.
  • Detailed profiles of phase III non-hormonal therapies being developed by players engaged in this domain.
  • A detailed geographical analysis of more than 220 completed and ongoing clinical studies of non-hormonal therapies based on several relevant parameters.
  • An analysis of the partnerships that have been established in this domain, in the recent past and analysis on various funding and investment instances reported within the non-hormonal therapy domain.
  • A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
  • Target Indication
  • Bacterial vaginosis
  • Contraception
  • Endometriosis
  • Postmenopausal Osteoporosis
  • Uterine fibroids
  • Vaginitis
  • Others

 

  • Type of Molecule
  • Biologics
  • Small molecules
  • Dendrimers

 

  • Route of Administration
  • Intramuscular
  • Intravaginal
  • Intravenous
  • Oral
  • Subcutaneous
  • Topical
  • Transdermal
  • Others

 

  • Key Geographical Regions
  • North America
  • Europe
  • Asia-Pacific

 

Key companies covered in the report

  • AbbVie
  • Astellas Pharma
  • Bayer
  • Daré Bioscience
  • Evofem Bioscience
  • Fougera Pharmaceuticals
  • Inmunotek
  • Mycovia Pharmaceuticals
  • Myovant Sciences
  • ObsEva
  • Radius Health
  • Scynexis

 

For more information please click on the following link:

https://www.rootsanalysis.com/reports/non-hormonal-therapies-for-women-health-market.html

 

Other Recent Offerings

  1. RNA Targeting Small Molecules Therapeutics Market: Industry Trends and Global Forecasts, 2021-2030
  2. Top Selling Biologics Market: Industry Trends and Global Forecasts, 2021-2030
  3. Peptide Therapeutics Market: Industry Trends and Global Forecasts, 2021-2030

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information:

Roots Analysis Private Limited

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com